Discusses ESMO Data on TGF-beta Receptor by PD-1 Bispecific in Colorectal Cancer and G12D Inhibitor in Pancreatic ...

In September 2024, Sanofi entered an exclusive licensing agreement with Orano Med and RadioMedix to globally commercialize ...

The US FDA has granted breakthrough therapy designation (BTD) to the bifunctional antibody ficerafusp alfa (BCA101) in ...

Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines targeting cancer and autoimmune ...

New hormonal and device-based methods could soon make male contraception reliable and reversible, offering alternatives to ...

212Pb-DOTAMTATE showed significant antitumor activity in PRRT-exposed GEP-NET patients, with a 34.6% ORR and 96.2% disease control rate per investigator review. Investigator-assessed 18-month PFS and ...

Ooops... Something went wrong while loading this page.

Analysts from William Blair and GlobalData critiqued the trial design for social anxiety disorder, though the latter notes ...

New research reveals that astrocytes — not neurons — are responsible for stabilizing emotional memories by re-engaging during recall.

PSMA antigen implicated in disease biology withcontinued expression following androgen receptor pathway inhibitor (ARPI) ...

Although experts may disagree on how to classify neurogenic rosacea pain, they advise dermatologists to get more comfortable ...

ATNM-400 is advancing as a first-in-class, multi-tumor Actinium-225 radiotherapy candidate with activity across prostate and lung cancers, two of the largest cancer indications globally New ...